The impact of clinical risk assessment versus PAM-50 ROR score on prognosis and therapeutic decision making in patients with hormone-receptor positive early stage breast cancer

Y Devyatko; M Filipits; Richard Greil; M Balic; Z Bago-Horvath; C Singer; F Fitzal; G Steger; B Gray; S Ferree; C Fesl; L Soelkner; G von Minckwitz; M Gnant

doi:10.1158/1538-7445.SABCS18-P1-17-05

The impact of clinical risk assessment versus PAM-50 ROR score on prognosis and therapeutic decision making in patients with hormone-receptor positive early stage breast cancer

Y Devyatko, M Filipits, Richard Greil, M Balic, Z Bago-Horvath, C Singer, F Fitzal, G Steger, B Gray, S Ferree, C Fesl, L Soelkner, G von Minckwitz, M Gnant

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Journal	CANCER RESEARCH
Volume	79
Issue number	4
DOIs	https://doi.org/10.1158/1538-7445.SABCS18-P1-17-05
Publication status	Published - 2019
Event	San Antonio Breast Cancer Symposium - San Antonio, TX Duration: 4 Dec 2018 → 8 Dec 2018

Access to Document

10.1158/1538-7445.SABCS18-P1-17-05

Cite this

Devyatko, Y., Filipits, M., Greil, R., Balic, M., Bago-Horvath, Z., Singer, C., Fitzal, F., Steger, G., Gray, B., Ferree, S., Fesl, C., Soelkner, L., von Minckwitz, G., & Gnant, M. (2019). The impact of clinical risk assessment versus PAM-50 ROR score on prognosis and therapeutic decision making in patients with hormone-receptor positive early stage breast cancer. CANCER RESEARCH , 79(4). https://doi.org/10.1158/1538-7445.SABCS18-P1-17-05

Devyatko, Y ; Filipits, M ; Greil, Richard et al. / The impact of clinical risk assessment versus PAM-50 ROR score on prognosis and therapeutic decision making in patients with hormone-receptor positive early stage breast cancer. In: CANCER RESEARCH 2019 ; Vol. 79, No. 4.

@article{7fddb1ef54bb46079a37a6f7d5bbd2db,

title = "The impact of clinical risk assessment versus PAM-50 ROR score on prognosis and therapeutic decision making in patients with hormone-receptor positive early stage breast cancer",

author = "Y Devyatko and M Filipits and Richard Greil and M Balic and Z Bago-Horvath and C Singer and F Fitzal and G Steger and B Gray and S Ferree and C Fesl and L Soelkner and {von Minckwitz}, G and M Gnant",

year = "2019",

doi = "10.1158/1538-7445.SABCS18-P1-17-05",

language = "English",

volume = "79",

journal = "CANCER RESEARCH ",

issn = "0008-5472",

publisher = "Amer Assoc Cancer Research",

number = "4",

note = "San Antonio Breast Cancer Symposium ; Conference date: 04-12-2018 Through 08-12-2018",

}

Devyatko, Y, Filipits, M, Greil, R, Balic, M, Bago-Horvath, Z, Singer, C, Fitzal, F, Steger, G, Gray, B, Ferree, S, Fesl, C, Soelkner, L, von Minckwitz, G & Gnant, M 2019, 'The impact of clinical risk assessment versus PAM-50 ROR score on prognosis and therapeutic decision making in patients with hormone-receptor positive early stage breast cancer', CANCER RESEARCH , vol. 79, no. 4. https://doi.org/10.1158/1538-7445.SABCS18-P1-17-05

The impact of clinical risk assessment versus PAM-50 ROR score on prognosis and therapeutic decision making in patients with hormone-receptor positive early stage breast cancer. / Devyatko, Y; Filipits, M; Greil, Richard et al.
In: CANCER RESEARCH , Vol. 79, No. 4, 2019.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - The impact of clinical risk assessment versus PAM-50 ROR score on prognosis and therapeutic decision making in patients with hormone-receptor positive early stage breast cancer

AU - Devyatko, Y

AU - Filipits, M

AU - Greil, Richard

AU - Balic, M

AU - Bago-Horvath, Z

AU - Singer, C

AU - Fitzal, F

AU - Steger, G

AU - Gray, B

AU - Ferree, S

AU - Fesl, C

AU - Soelkner, L

AU - von Minckwitz, G

AU - Gnant, M

PY - 2019

Y1 - 2019

U2 - 10.1158/1538-7445.SABCS18-P1-17-05

DO - 10.1158/1538-7445.SABCS18-P1-17-05

M3 - Abstract (Journal)

SN - 0008-5472

VL - 79

JO - CANCER RESEARCH

JF - CANCER RESEARCH

IS - 4

T2 - San Antonio Breast Cancer Symposium

Y2 - 4 December 2018 through 8 December 2018

ER -

Devyatko Y, Filipits M, Greil R, Balic M, Bago-Horvath Z, Singer C et al. The impact of clinical risk assessment versus PAM-50 ROR score on prognosis and therapeutic decision making in patients with hormone-receptor positive early stage breast cancer. CANCER RESEARCH . 2019;79(4). doi: 10.1158/1538-7445.SABCS18-P1-17-05